These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization. Maa YF; Shu C; Ameri M; Zuleger C; Che J; Osorio JE; Payne LG; Chen D Pharm Res; 2003 Jul; 20(7):969-77. PubMed ID: 12880281 [TBL] [Abstract][Full Text] [Related]
31. Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine. Hu Y; Smith D; Zhao Z; Harmon T; Pentel PR; Ehrich M; Zhang C Nanomedicine; 2019 Aug; 20():102023. PubMed ID: 31181264 [TBL] [Abstract][Full Text] [Related]
32. Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice. Magnusson SE; Reimer JM; Karlsson KH; Lilja L; Bengtsson KL; Stertman L Vaccine; 2013 Mar; 31(13):1725-33. PubMed ID: 23384754 [TBL] [Abstract][Full Text] [Related]
33. Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice. Wang XY; Yao X; Wan YM; Wang B; Xu JQ; Wen YM Immunol Lett; 2013 Jan; 149(1-2):88-92. PubMed ID: 23183095 [TBL] [Abstract][Full Text] [Related]
34. Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines. Tegenge MA; Von Tungeln LS; Anderson SA; Mitkus RJ; Vanlandingham MM; Forshee RA; Beland FA Regul Toxicol Pharmacol; 2019 Nov; 108():104436. PubMed ID: 31381939 [TBL] [Abstract][Full Text] [Related]
36. Effect of Autoclaving on the Physicochemical Properties and Biological Activity of Aluminum Oxyhydroxide Used as an Adjuvant in Vaccines. Skiba M; Fatmi S; Milon N; Bounoure F; Lahiani-Skiba M Molecules; 2023 Jan; 28(2):. PubMed ID: 36677641 [TBL] [Abstract][Full Text] [Related]
37. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. Seubert A; Monaci E; Pizza M; O'Hagan DT; Wack A J Immunol; 2008 Apr; 180(8):5402-12. PubMed ID: 18390722 [TBL] [Abstract][Full Text] [Related]
38. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles. Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and biodistribution of squalene-containing emulsion adjuvant following intramuscular injection of H5N1 influenza vaccine in mice. Tegenge MA; Von Tungeln LS; Mitkus RJ; Anderson SA; Vanlandingham MM; Forshee RA; Beland FA Regul Toxicol Pharmacol; 2016 Nov; 81():113-119. PubMed ID: 27498239 [TBL] [Abstract][Full Text] [Related]
40. The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization. Ebensen T; Delandre S; Prochnow B; Guzmán CA; Schulze K Front Cell Infect Microbiol; 2019; 9():31. PubMed ID: 30838180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]